Electroconvulsive therapy, commonly called ECT and often referred to colloquially as “shock therapy,” is legal throughout the United States and in most countries worldwide. It is not, however, unregulated. The legal landscape around ECT is a patchwork of federal device classification, state-level restrictions, informed consent requirements, and international human rights debates that vary dramatically depending on where you live and who the patient is. The result is a treatment that is simultaneously endorsed by mainstream psychiatry and subject to more legal scrutiny than almost any other medical procedure.
Federal Regulation in the United States
In the US, ECT devices are regulated by the Food and Drug Administration. For decades, ECT devices sat in the FDA’s most restrictive category, Class III, which is reserved for high-risk devices like pacemakers and artificial hearts. That changed in 2018, when the FDA issued a final order reclassifying ECT devices to Class II for specific uses: treating catatonia or a severe major depressive episode linked to major depressive disorder or bipolar disorder, in patients aged 13 and older who either haven’t responded to other treatments or need a rapid response because of the severity of their condition.1PubMed. Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Class II means the devices are subject to special controls but don’t require the most burdensome premarket approval process.
For any use outside those specific indications, ECT devices remain Class III, and manufacturers would need to file a premarket approval application. In practice, this means the FDA has drawn a line: ECT for treatment-resistant depression and catatonia is considered to have a favorable enough risk-benefit profile to warrant a streamlined regulatory path, while use for other psychiatric conditions faces a much higher bar. That distinction matters because it shapes which insurance plans cover ECT and how hospitals justify offering it.
It’s worth noting that the FDA regulates the device itself, not the clinical decision to use it. A psychiatrist prescribing ECT for a condition outside the Class II indications isn’t necessarily breaking federal law, but they’re using a device in a way that hasn’t received the same level of regulatory endorsement. This is similar to off-label prescribing of medications, which is legal but carries different liability implications.
State Laws Are All Over the Map
There is no national law in the United States governing who can receive ECT, who can consent to it, or what reporting requirements practitioners must meet. That job falls to individual state governments, and the variation is enormous.2The Journal of ECT. Regulation of Electroconvulsive Therapy: A Systematic Review of US State Laws Some states have detailed statutes covering every aspect of the procedure. Others have no ECT-specific regulation at all, leaving the treatment governed only by general medical practice laws and institutional policies.
The areas where states diverge most sharply include:
- Who can receive ECT: Some states set minimum age requirements or restrict use in specific populations such as pregnant individuals or people with certain medical conditions. Others leave eligibility entirely to clinical judgment.
- Consent procedures: Some states require written informed consent with specific disclosures about risks, alternatives, and the right to withdraw. Others rely on general medical consent law.
- Who can prescribe or perform ECT: A handful of states specify that only board-certified psychiatrists or physicians with particular training can administer the treatment. In states without such rules, hospital credentialing committees fill the gap.
- Reporting and oversight: Some states require facilities to report ECT usage data to a state agency. Others impose no reporting requirement, making it difficult to track how often the treatment is used or on whom.
This patchwork means your legal protections as a patient depend significantly on your zip code. A person receiving ECT in California, which has some of the most detailed ECT statutes in the country, has a different set of legal rights than someone in a state with no ECT-specific law on the books.
Informed Consent and the Right to Refuse
Informed consent is the legal and ethical cornerstone of ECT practice, and it is also where the most contentious debates play out. In theory, a patient must understand the nature of the procedure, its risks and benefits, and available alternatives before agreeing to treatment. In practice, this gets complicated fast when the patient in question is experiencing a severe psychiatric crisis that impairs their ability to make decisions.
This creates what ethicists describe as a genuine dilemma: respecting patient autonomy and providing the best available medical care can pull in opposite directions when a severely ill person refuses a treatment that clinicians believe could help them.3PubMed Central. Electroconvulsive therapy and informed consent in compulsory treatment – an ethical dilemma The legal question is whether, and under what circumstances, ECT can be administered over a patient’s objection.
The answer varies by jurisdiction, but most legal frameworks allow involuntary ECT only under narrow conditions: when a patient has been found to lack decision-making capacity through a formal assessment, when the treatment is deemed medically necessary, and usually when a court or independent review body has approved the decision. In some states, a court order is always required before ECT can be given without consent. In others, the treating psychiatrist and a second opinion may be sufficient.
A retrospective study of medical records found that specific documentation of a patient’s capacity to consent to ECT was generally lacking, suggesting that the formal safeguards on paper don’t always translate to rigorous practice.4PubMed. Autonomy and consent assessment for electroconvulsive therapy (ECT) This gap between law and implementation is a recurring theme in ECT regulation globally.
ECT Without Consent in England
England offers a useful case study in how a country can have relatively detailed ECT legislation and still struggle with compliance. Under the Mental Health Act, ECT can be given without consent only if a second-opinion doctor, appointed by the regulatory body, certifies that the treatment is appropriate. Government guidelines from the National Institute for Health and Care Excellence (NICE) also require that psychological therapy be considered before ECT.
An independent audit of ECT practice across England found that more than a third of all ECT was administered without patient consent, and roughly one in five NHS Trusts were non-compliant with the legislation requiring second opinions.5PubMed. A second independent audit of electroconvulsive therapy in England, 2019 Only one Trust in the entire country could even report how many patients had received psychological therapy before ECT, as the NICE guidelines require. These findings point to a broader problem: even well-intentioned regulatory frameworks can fail when monitoring and enforcement are weak.
An earlier audit covering 2011 to 2015 had flagged many of the same concerns, including the absence of comprehensive national auditing of ECT practice.6PubMed. An audit of ECT in England 2011-2015 The persistence of these gaps across multiple audits suggests systemic issues rather than isolated failures.
Psychiatric Advance Directives
One legal tool that has gained attention in ECT debates is the psychiatric advance directive, or PAD. A PAD lets a person spell out their treatment preferences while they are well, so those preferences can guide care during a future crisis when they may not be able to communicate clearly. In the context of ECT, PADs are often discussed as a way for people to refuse the treatment in advance. But they can work in the other direction too: a legislative review of Australian law noted that PADs can also serve as a way for people to consent to ECT ahead of time, giving them more control over their own care rather than leaving the decision to clinicians or courts during a crisis.7PubMed. Psychiatric advance directives and consent to electroconvulsive therapy (ECT) in Australia
The legal weight of PADs varies. In some jurisdictions, they are binding on clinicians unless specific override conditions are met. In others, they are advisory, meaning a doctor can override a PAD if they believe doing so is in the patient’s best interest. For someone who feels strongly about ECT in either direction, finding out whether your local laws give PADs binding force is a practical first step.
International Human Rights and Disability Law
At the international level, ECT sits at the intersection of medical practice and human rights law. The United Nations Convention on the Rights of Persons with Disabilities (CRPD) has become a touchstone in these debates. The CRPD affirms the right of people with disabilities, including psychiatric disabilities, to make their own decisions and to be free from treatment administered without consent.
Critics of involuntary ECT argue that administering the treatment over a patient’s objection violates the CRPD’s protections, particularly because patients in psychiatric institutions are especially vulnerable to receiving intrusive treatments without meaningful consent.8International Journal of Legal Information. No Means No, Or Does It? A Comparative Study of the Right to Refuse Treatment in a Psychiatric Institution From this perspective, involuntary ECT is not merely a medical decision but a human rights issue that implicates a person’s bodily autonomy and dignity.
On the other side, psychiatric professional organizations argue that withholding ECT from a patient who cannot consent but is suffering severely, when the treatment has a strong evidence base, can also be a form of harm. This tension has not been resolved at the international level, and different countries have landed in very different places. Some nations have banned involuntary ECT outright, while others permit it under judicial or administrative oversight.
How Modern ECT Differs from Its Reputation
Much of the public’s discomfort with ECT traces back to its history. Early unmodified ECT, before anesthesia was incorporated, was widely viewed as inhumane. Patients were awake, experienced the full force of the electrically induced seizure, and suffered fractures and other injuries. The sociopolitical backlash was so severe that ECT was banned from use in some parts of the United States for a period.9PubMed. The Historical Struggles of Modified Electroconvulsive Therapy: How Anesthesia Came to the Rescue
Modern ECT looks almost nothing like that. Patients receive general anesthesia and a muscle relaxant, so they are unconscious and their body doesn’t convulse visibly. The electrical stimulus is brief and carefully calibrated. Research into the biological mechanisms suggests that ECT triggers widespread neuroplasticity, including changes in the thickness of brain regions involved in mood regulation, and that these structural changes correlate with the degree of antidepressant response.10PubMed Central. Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex The therapeutic effects appear to involve a cascade of neurochemical, genetic, and connectivity changes in the brain.11PubMed Central. How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms
None of this means ECT is without side effects. Memory disruption is the most commonly cited concern, and it plays directly into legal disclosure requirements. A study tracking patients before, after, and at follow-up found that retrograde amnesia, meaning difficulty recalling events from before the treatment, was present immediately after ECT but had returned to pre-treatment levels at follow-up. Memory for events in the months after treatment was comparable to that of people who hadn’t received ECT.12PubMed Central. Retrograde amnesia after electroconvulsive therapy: a temporary effect? However, some patients report persistent memory gaps, and the extent of cognitive effects remains a point of disagreement within the field. Legally, these risks must be disclosed during the consent process in jurisdictions with specific ECT statutes.
ECT Is Not the Same as Aversion Therapy
A persistent source of confusion in public discussions is the conflation of ECT with electrical stimulation devices (ESDs) used as aversion therapy, where painful shocks are applied to the skin to suppress unwanted behaviors. These are entirely different treatments with different purposes, different mechanisms, and very different legal trajectories.
The FDA moved in 2020 to ban electrical stimulation devices used for self-injurious or aggressive behavior, a decision primarily targeting a single facility that had been using such devices on people with developmental disabilities. The agency’s evaluation found that these devices posed risks including depression, PTSD, anxiety, panic, skin burns, tissue damage, chronic stress, and suicidality, and that the available evidence had not established a durable long-term benefit or a favorable risk-benefit profile.13Federal Register. Banned Devices; Proposal To Ban Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior
This ban has nothing to do with ECT. ECT delivers a brief electrical stimulus to the brain under general anesthesia to induce a therapeutic seizure. Aversion therapy devices deliver painful shocks to the body to punish behavior. The FDA’s willingness to ban one while reclassifying the other to a less restrictive category reflects the agency’s view that these are fundamentally different technologies with fundamentally different evidence bases. When people ask whether “shock therapy” is legal, the answer depends entirely on which treatment they mean.
Racial Disparities in Who Gets ECT
Legal access to ECT and practical access are not the same thing. Even where ECT is fully legal and available, significant disparities exist in who actually receives it. A large study of hospital data found that among depressed inpatients, white patients were far more likely to receive ECT than Black patients. The probability of receiving ECT was about 7% for white inpatients compared to 2% for Black inpatients. Part of the gap came from slight differences in whether ECT was available at the hospitals where patients were treated, but the larger driver was differences in use: among patients at hospitals where ECT was available, white patients were roughly three times as likely to receive it as Black patients.14PubMed Central. Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression
Research into the causes of this disparity points to clinician-level bias. Studies have found that patients of color are more likely to be misdiagnosed with psychotic-spectrum disorders rather than severe affective disorders, and since affective disorders are the primary indication for ECT referral, this diagnostic bias creates a downstream disparity in who gets referred for the treatment.15PubMed. Clinicians’ Racial Bias Contributing to Disparities in Electroconvulsive Therapy for Patients From Racial-Ethnic Minority Groups Even after receiving a correct affective diagnosis, patients from minority groups may face additional bias in treatment selection. This isn’t strictly a legal question, but it shapes the real-world impact of ECT laws: a legal right to receive a treatment doesn’t mean much if systemic bias prevents you from being referred for it in the first place.
Where Countries Have Banned or Severely Restricted ECT
While ECT is legal in most of the developed world, a few countries and regions have imposed outright bans or near-bans. Slovenia banned ECT entirely for a period before later lifting the ban. Several Indian states restricted or prohibited its use under certain conditions, particularly for minors and individuals unable to consent, before national clinical practice guidelines helped standardize its regulation. In Italy, some regions imposed significant restrictions following public campaigns against the treatment, though ECT remains available at major academic medical centers.
These bans have generally been driven more by public sentiment and political pressure than by medical consensus. Major psychiatric organizations, including the American Psychiatric Association, the Royal College of Psychiatrists, and the World Psychiatric Association, endorse ECT as an effective treatment for specific conditions. The gap between professional medical opinion and public perception keeps the legal status of ECT politically charged in ways that few other medical procedures experience. A patient considering ECT is navigating not just their own medical needs but a decades-long cultural argument about psychiatry, autonomy, and the boundary between treatment and coercion.
What You Can Do to Protect Your Rights
If you or a family member is considering ECT, or is concerned about the possibility of receiving it involuntarily, there are concrete steps you can take. Look up your state’s specific ECT laws, because the protections available vary dramatically. Ask your treatment team exactly what consent procedures they follow and request written documentation. If your state recognizes psychiatric advance directives, consider creating one while you are well enough to make decisions clearly. If involuntary ECT is being proposed for a family member, find out whether your jurisdiction requires a court order or independent review, and request legal representation if it does. Advocacy organizations focused on psychiatric patient rights can help you understand the specific regulations that apply in your area and connect you with legal resources if you feel those regulations are not being followed.